FEDERAL STREET STRATEGIES, LLC

Lobbying for BRISTOL MYERS SQUIBB COMPANY · Global biopharmaceutical company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $30,000.00 income · posted Apr 21, 2025

Lobbying activity 1

Health Issues

Access to prescription drugs. Drug Pricing reform/implementation. Monitor Food is Medicine initiatives.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.